Data Report
Covid19 => Covid Treatments => Topic started by: Steve on September 05, 2023, 07:38:14 pm
-
SUMMARY - The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has approved the Pfizer/BioNTech COVID-19 vaccine that targets the Omicron XBB 1.5 subvariant. The vaccine has been approved for persons who are 6 months and older.
LINK - https://www.gov.uk/government/news/mhra-approves-pfizerbiontechs-adapted-covid-19-vaccine-comirnaty-that-targets-omicron-xbb15 (https://www.gov.uk/government/news/mhra-approves-pfizerbiontechs-adapted-covid-19-vaccine-comirnaty-that-targets-omicron-xbb15)